| Dose
|
Single Dose
|
Frequency
|
Route
|
Instructions
|
Adult Dosage
|
| 5 mg | 5 (5) | 24 hourly | PO | For treatment and prevention of Postmenopausal Osteoporosis: |
| 5 mg | 5 (5) | 24 hourly | PO | Treatment and Prevention of Glucocorticoid-Induced Osteoporosis: |
| 30 mg | 30 (30) | 24 hourly | PO | Treatment of Paget''s Disease :Retreatment may be considered (following post-treatment observation of at least 2 months) if relapse occurs, or if treatment fails to normalize serum alkaline phosphatase. |
| 35 mg | 35 (35) | As recommended. | PO | Treatment to Increase Bone Mass in Men with Osteoporosis: Taken once a week. |
Paedriatic Dosage (20kg)
|
| No data regarding the Paedriatic dosage details of Risedronate (Na) is available. |
Neonatal Dosage (3kg)
|
| No data regarding the neonatal dosage details of Risedronate (Na) is available. |